The Mumbai-based firm’s consolidated revenue from operations rose to ₹7,051.02 crore in the September quarter, up from ₹6,678 ...

While mid-single-digit growth for FY25 is expected, Investec sees continued weakness in demand for entry-level cars, partially due to a consumer shift towards premium vehicles.

Brokerage firms have given a mixed reaction to the shares of drug maker CIPLA Ltd. The pharma company announced its results ...

Stocks including Reliance Industries, Torrent Pharma, L&T, Voltas, RITES, Marico, Concor, Godavari Biorefineries and more ...